Pexmachina
5 employees on LinkedIn · 1 known investors
Find your way into Pexmachina
194 people in our graph share verified history with the Pexmachina team — schools, employers, funds. One of them is your warm intro.
Oliver Manojlovicunlockedknows Matthias Kaiser · together at Goethe University Frankfurt (overlapped)
×4knows the team · via University of Vienna
knows the team · via Rīgas Ekonomikas augstskola - Stockholm School of Economics in Riga
×6knows the team · via Goethe University Frankfurt
PexMachina develops physics-based molecular simulation for drug discovery, using quantum-ready computational chemistry and AI agents to predict properties like binding, stability, and oral availability of peptides. It delivers its PexAgent as an MCP service that integrates into LLM platforms such as Claude and Gemini, letting pharmaceutical researchers run molecular simulations via natural language within existing R&D workflows.
Founders & leadership
MK
Matthias KaiserinFounderMatthias Kaiser holds a Master's degree in Physics with a focus on theoretical quantum information theory from the University of Vienna. He has over 13 years of experience in business development and commercialization in tech and deep-tech sectors, and previously founded a company in industrial optimization and AI before starting PexMachina.
Investors · 1
Frequently asked questions
- What does Pexmachina do?
- PexMachina develops physics-based molecular simulation for drug discovery, using quantum-ready computational chemistry and AI agents to predict properties like binding, stability, and oral availability of peptides. It delivers its PexAgent as an MCP service that integrates into LLM platforms such as Claude and Gemini, letting pharmaceutical researchers run molecular simulations via natural language within existing R&D workflows.
- Who founded Pexmachina?
- Pexmachina was founded by Matthias Kaiser.
- Who are Pexmachina's investors?
- Pexmachina's investors include QAI Ventures.